{"id":"W4410156931","doi":"10.1001/jamadermatol.2025.1136","title":"Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body","year":2025,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Probity Medical Research; Western University; SKiN Health; Queen's University","funders":"Pfizer; Eli Lilly and Company; Sun Pharma; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Scalp; Tolerability; Randomized controlled trial; Psoriasis; Clinical endpoint; Randomization; Adverse effect; Roflumilast; Internal medicine; Physical therapy; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001129294,0.0004175396,0.0008157534,0.0002870927,0.0002153492,0.0004463707,0.0003301027,0.000596739,0.003696717],"category_scores_gemma":[0.0009776568,0.0001929764,0.0004541455,0.0002898791,0.000412028,0.0004460761,0.0001092752,0.0008547279,0.0004699812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002597232,"about_ca_system_score_gemma":0.0006929873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007262722,"about_ca_topic_score_gemma":0.002818832,"domain_scores_codex":[0.9995466,0.0002345508,0.00003307029,0.00005371285,0.00007420167,0.0000578048],"domain_scores_gemma":[0.9993585,0.0002429906,0.0002172807,0.00002778168,0.00005338874,0.0001001001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5942243,0.01911685,0.008083951,0.00408431,0.001131035,0.0002428628,0.0001462566,0.0005521154,0.08464824,0.0002597577,0.002561941,0.2849483],"study_design_scores_gemma":[0.5701861,0.3852151,0.02391444,0.00026037,0.001215645,0.0005965027,0.00009296776,0.0009351147,0.01148001,0.0002023537,0.005867202,0.00003411893],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747218,0.01783436,0.001074828,0.0004700287,0.0001617381,0.00234028,0.0004256246,0.0001233792,0.002848019],"genre_scores_gemma":[0.9904091,0.004757984,0.001620209,0.0003064955,0.0002660312,0.001009955,0.0002703872,0.00001349519,0.001346353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003696717,"threshold_uncertainty_score":0.01236671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008634013456365299,"score_gpt":0.2368850056218592,"score_spread":0.2282509921654939,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}